30 research outputs found
66 Tigatuzumab, a novel anti-human death receptor 5 antibody, shows synergistic efficacy against colon cancer in vitro and in vivo in combination with chemotherapy
Full text link
Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy
No full textHigh dielectric constant polymer-ceramic (Epoxy varnish-barium titanate) nanocomposites at moderate filler loadings for embedded capacitors
No full textDiscovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer
No full textTrastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective
No full textComparison of theoretical predictions and experimental values of the dielectric constant of epoxy/BaTiO3 composite embedded capacitor films
No full text
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
No full text
